Clinical Trial Optimization Podcast
Discussing the major issues affecting you, from quality-by-design, to risk-based quality management and vendor oversight.
Subscribe today!
Apple Podcasts Spotify Stitcher AndroidDISCOVER MORE WCG PODCASTS ›
Hosted by: Linda Sullivan
MCC Founder and Former WCG Avoca Senior Advisor, Metrics & Performance Management
EPISODE 45
Heard It on the Street: Three Actions Industry Should Take To Improve Clinical Trial Design and Execution with WCG MAGI Clinical Research Conference Attendees
EPISODE 44
WCG Innovation Challenge Finalist Temple University Discuss Closing Gap Between Clinical Research and Clinical Care
EPISODE 43
WCG Innovation Challenge Finalist Sanofi Discusses Benefits of Collaborating with Patients to Improve Clinical Research Design & Outcomes
EPISODE 42
WCG Innovation Challenge Finalist St Lawrence Health Discusses Evaluating Job Candidates’ Soft Skills
EPISODE 41
WCG Innovation Challenge Finalist Boston Children’s Hospital Discusses DEI Workforce Development Program
EPISODE 40
WCG Innovation Challenge Winner Bayer Discusses Kits4Life Program
EPISODE 39
How New Trial Designs & the Pandemic Have Altered Risk-Based Monitoring with Duncan Hall
EPISODE 38
Deploying Advanced Analytics to Enhance QA with Timothé Ménard
EPISODE 37
The Evolving Role of the QA Professional with David Fryrear
EPISODE 36
QTLs & Early Detection of Risk (Part III of the QTL Series) with Steve Young, Keith Dorricott, and WCG Senior Advisor Linda Sullivan
EPISODE 35
Defining QTLs & KRIs that Detect Risks in a Timely Manner (Part II) — The Process of Defining QTLs with Steve Young, Keith Dorricott, and Linda Sullivan
EPISODE 34
Defining QTLs and KRIs that Detect Risks in a Timely Manner – Part 1 Relationship of QTLs & KRIs with Steve Young, Keith Dorricott, and Linda Sullivan
EPISODE 33
Improving Enrollment of Underrepresented Racial and Ethnic Populations in Clinical Trials with WCG’s Lori Abrams and Linda Sullivan
EPISODE 32
How the Pandemic Has Impacted Clinical Research Sites with WCG’s Sandy Smith and Linda Sullivan
EPISODE 31
The MCC – Avoca Quality Consortium Integration — Latest Developments with WCG AQC VP Michelle Webb and Linda Sullivan
EPISODE 30
Optimizing the Potential of Artificial Intelligence in Clinical Trials with Jonathan Rowe of ZS and Linda Sullivan
EPISODE 29
What the New, Combined MCC/AQC Consortium Means for the Clinical Trials Industry with AQC’s Patty Leuchten and Linda Sullivan
EPISODE 28
Highlights from 4th Annual WCG MCC Clinical Trial Risk and Performance Management Virtual Collaborative Summit with Keith Dorricott and Linda Sullivan
EPISODE 27
How Small Sponsors Can Best Access Clinical Trial Data with Lokavant’s Rohit Nambisan and Todd Johnson and Linda Sullivan
EPISODE 26
Outsourcing Oversight of RBQM in Clinical Trials with Liz Wool and Linda Sullivan
EPISODE 25
Grouping Investigative Sites into Risk Groups for “Fit for Purpose” Monitoring with Tammy Finnigan, Elizabeth Robertson, and Linda Sullivan
EPISODE 24
RBQM in Clinical Research with Cyntegrity’s Artem Andrianov and Johann Proeve and Linda Sullivan
EPISODE 23
Optimizing Central Monitoring with Pfizer’s Crupa Kurien and Linda Sullivan
EPISODE 22
RBQM’s Maturity Model with Sam Sather of Clinical Pathways and Linda Sullivan
EPISODE 21
Optimizing Quality by Design with Keith Dorricott and Linda Sullivan
EPISODE 20
Optimizing Patient Diversity and Engagement with Lori Abrams and Linda Sullivan
EPISODE 19
Optimizing Clinical Trial Monitoring with Keith Dorricott and Linda Sullivan
EPISODE 18
How Organizations Can Take Advantage of Risk Assessment and Mitigation Management Tool To Optimize Clinical Trials with Keith Dorricott and Linda Sullivan
EPISODE 17
How Organizations Can Decide Which Metrics To Implement To Optimize Clinical Trials with Keith Dorricott and Linda Sullivan
EPISODE 16
How MCC Work Groups Develop Metric Toolkits with Keith Dorricott and Linda Sullivan
EPISODE 15
New Benchmarks on Protocol Design Practices and their Impact on Clinical Trial Performance and Efficiency with Ken Getz and Linda Sullivan
EPISODE 14
Twin Peaks — Measurements & Goals: Pros and Cons of Using High-Level Portfolio Milestone Timeliness Metrics with Linda Sullivan and Keith Dorricott
EPISODE 13
You’ve Detected a Risk … Now What?! The Challenges Organizations Face Accepting and Acting on Risks Identified by Centralized Monitoring with Linda Sullivan, Steve Young, and Keith Dorricott
EPISODE 12
Deploying Streamlined Surveys and Generating Metrics to Assess Vendor-Sponsor Relationships with Linda Sullivan and Keith Dorricott
EPISODE 11
TMF Accredited Training Program is Key To Building Your World-Class TMF with Linda Sullivan and Sholeh Ehdaivand
EPISODE 10
How the Right Metrics Enable You to Develop World-Class Sponsor-CRO Relationships with Linda Sullivan, Steve Crow, and Keith Dorricott
EPISODE 9
Implementing the Successful Total Cost of Quality Model in Clinical Trials: Yes, You Can — and Must — Eliminate Waste with Linda Sullivan and Keith Dorricott
EPISODE 8
Implementing Successful RBQM Programs Requires Three-Pronged Approach — It’s Not Just Software Implementation, with Linda Sullivan and Gary Tyson
EPISODE 7
Optimizing Human Performance in Clinical Trials by Applying Gilbert’s Behavioral Engineer Model with Linda Sullivan and SAM Sather
EPISODE 6
The Case for Centralized Monitoring: Optimizing Data Quality and Risk Management with Linda Sullivan and Steve Young
EPISODE 5
Striving for Reliability: Optimizing Patient-Reported Data through World-Class Design Management with Linda Sullivan, Nat Katz, and Art Morales
EPISODE 4
The Upside of Centralized Monitoring During a Pandemic: Linda Sullivan, Duncan Hall, and Rachel Oakley on Optimizing Clinical Trials through Innovative RBQM Technology
EPISODE 3
Get Rid of Those Silos: Linda Sullivan, Artem Andrianov, and Johann Proeve on How To Optimize Clinical Trials through RBQM
EPISODE 2
Turning Insights Into Action: Linda Sullivan and Ken Getz on How Metrics and Benchmarking Provide a Path To Optimizing Clinical Trials
EPISODE 1